Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Gross Margin (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Gross Margin for 3 consecutive years, with 97.41% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 219.0% to 97.41% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 98.73% through Dec 2025, down 39.0% year-over-year, with the annual reading at 98.73% for FY2025, 39.0% down from the prior year.
  • Gross Margin hit 97.41% in Q4 2025 for Immunocore Holdings, down from 99.51% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 99.71% in Q4 2023 to a low of 97.41% in Q4 2025.
  • Historically, Gross Margin has averaged 99.14% across 3 years, with a median of 99.47% in 2024.
  • Biggest YoY gain for Gross Margin was 120bps in 2025; the steepest drop was -219bps in 2025.
  • Year by year, Gross Margin stood at 99.71% in 2023, then dropped by 0bps to 99.61% in 2024, then dropped by -2bps to 97.41% in 2025.
  • Business Quant data shows Gross Margin for IMCR at 97.41% in Q4 2025, 99.51% in Q3 2025, and 98.94% in Q2 2025.